Legislature(2009 - 2010)CAPITOL 120

03/10/2010 01:00 PM JUDICIARY


Download Mp3. <- Right click and save file as

* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
*+ HB 327 CONTROLLED SUBSTANCES/DEXTROMETHORPHAN TELECONFERENCED
Moved CSHB 327(JUD) Out of Committee
+ HB 115 PERMANENT ABSENTEE VOTING TELECONFERENCED
Heard & Held
*+ HB 355 CRIMINAL FINES FOR ORGANIZATIONS TELECONFERENCED
Heard & Held
+ Bills Previously Heard/Scheduled TELECONFERENCED
                    ALASKA STATE LEGISLATURE                                                                                  
               HOUSE JUDICIARY STANDING COMMITTEE                                                                             
                         March 10, 2010                                                                                         
                           1:07 p.m.                                                                                            
                                                                                                                                
MEMBERS PRESENT                                                                                                               
                                                                                                                                
Representative Jay Ramras, Chair                                                                                                
Representative Nancy Dahlstrom, Vice Chair                                                                                      
Representative Carl Gatto                                                                                                       
Representative Bob Herron                                                                                                       
Representative Bob Lynn                                                                                                         
Representative Max Gruenberg                                                                                                    
Representative Lindsey Holmes                                                                                                   
                                                                                                                                
MEMBERS ABSENT                                                                                                                
                                                                                                                                
All members present                                                                                                             
                                                                                                                                
COMMITTEE CALENDAR                                                                                                            
                                                                                                                                
HOUSE BILL NO. 327                                                                                                              
"An Act relating to the scheduling and rescheduling of certain                                                                  
substances as controlled substances and to the sale of products                                                                 
containing dextromethorphan."                                                                                                   
                                                                                                                                
     - MOVED CSHB 327(JUD) OUT OF COMMITTEE                                                                                     
                                                                                                                                
HOUSE BILL NO. 115                                                                                                              
"An Act establishing a permanent absentee voting option for                                                                     
qualified voters; and providing for an effective date."                                                                         
                                                                                                                                
     - HEARD & HELD                                                                                                             
                                                                                                                                
HOUSE BILL NO. 355                                                                                                              
"An Act relating to criminal fines for organizations."                                                                          
                                                                                                                                
     - HEARD & HELD                                                                                                             
                                                                                                                                
PREVIOUS COMMITTEE ACTION                                                                                                     
                                                                                                                                
BILL: HB 327                                                                                                                  
SHORT TITLE: CONTROLLED SUBSTANCES/DEXTROMETHORPHAN                                                                             
SPONSOR(S): REPRESENTATIVE(S) JOHANSEN                                                                                          
                                                                                                                                
02/05/10       (H)       READ THE FIRST TIME - REFERRALS                                                                        
02/05/10       (H)       JUD                                                                                                    
03/10/10       (H)       JUD AT 1:00 PM CAPITOL 120                                                                             
                                                                                                                                
BILL: HB 115                                                                                                                  
SHORT TITLE: PERMANENT ABSENTEE VOTING                                                                                          
SPONSOR(S): REPRESENTATIVE(S) BUCH                                                                                              
                                                                                                                                
02/04/09       (H)       READ THE FIRST TIME - REFERRALS                                                                        
02/04/09       (H)       STA, FIN                                                                                               
03/17/09       (H)       STA AT 8:00 AM CAPITOL 106                                                                             
03/17/09       (H)       Heard & Held                                                                                           
03/17/09       (H)       MINUTE(STA)                                                                                            
02/18/10       (H)       STA AT 8:00 AM CAPITOL 106                                                                             
02/18/10       (H)       Moved CSHB 115(STA) Out of Committee                                                                   
02/18/10       (H)       MINUTE(STA)                                                                                            
02/19/10       (H)       JUD REFERRAL ADDED AFTER STA                                                                           
02/23/10       (H)       STA RPT CS(STA) 3DP 2NR                                                                                
02/23/10       (H)       DP: SEATON, GRUENBERG, PETERSEN                                                                        
02/23/10       (H)       NR: P.WILSON, LYNN                                                                                     
03/10/10       (H)       JUD AT 1:00 PM CAPITOL 120                                                                             
                                                                                                                                
BILL: HB 355                                                                                                                  
SHORT TITLE: CRIMINAL FINES FOR ORGANIZATIONS                                                                                   
SPONSOR(S): REPRESENTATIVE(S) GRUENBERG                                                                                         
                                                                                                                                
02/19/10       (H)       READ THE FIRST TIME - REFERRALS                                                                        
02/19/10       (H)       JUD, FIN                                                                                               
03/10/10       (H)       JUD AT 1:00 PM CAPITOL 120                                                                             
                                                                                                                                
WITNESS REGISTER                                                                                                              
                                                                                                                                
REPRESENTATIVE KYLE JOHANSEN                                                                                                    
Alaska State Legislature                                                                                                        
Juneau, Alaska                                                                                                                  
POSITION STATEMENT:  Sponsor of HB 327.                                                                                       
                                                                                                                                
DAVID SCOTT, Staff                                                                                                              
Representative Kyle Johansen                                                                                                    
Alaska State Legislature                                                                                                        
Juneau, Alaska                                                                                                                  
POSITION STATEMENT:  Assisted with the presentation of HB 327 on                                                              
behalf of the sponsor, Representative Johansen.                                                                                 
                                                                                                                                
SUE STANCLIFF, Special Assistant                                                                                                
Office of the Commissioner                                                                                                      
Department of Public Safety (DPS)                                                                                               
Anchorage, Alaska                                                                                                               
POSITION STATEMENT:  Testified in support of HB 327.                                                                          
                                                                                                                                
LELA RAYMOND                                                                                                                    
Ketchikan, Alaska                                                                                                               
POSITION STATEMENT:  During discussion of HB 327, spoke about                                                                 
dextromethorphan abuse.                                                                                                         
                                                                                                                                
REND AL-MONDHIRY, Esq., State Legislative Counsel                                                                               
Legal & Government Affairs                                                                                                      
Consumer Healthcare Products Association (CHPA)                                                                                 
Washington, D.C.                                                                                                                
POSITION STATEMENT:  During discussion of HB 327, expressed                                                                   
concern with the provisions pertaining to dextromethorphan.                                                                     
                                                                                                                                
RENEE SCHOFIELD, CEO                                                                                                            
Tongass Substance Screening, Inc. (TSS)                                                                                         
Ketchikan, Alaska                                                                                                               
POSITION STATEMENT:  Testified in support of HB 327.                                                                          
                                                                                                                                
BARRY CHRISTENSEN, Co-Chair                                                                                                     
Legislative Committee                                                                                                           
Alaska Pharmacists Association (APA)                                                                                            
Ketchikan, Alaska                                                                                                               
POSITION STATEMENT:  During discussion of HB 327, testified in                                                                
opposition to the provisions pertaining to dextromethorphan.                                                                    
                                                                                                                                
GERALD LUCKHAUPT, Attorney                                                                                                      
Legislative Legal Counsel                                                                                                       
Legislative Legal and Research Services                                                                                         
Legislative Affairs Agency (LAA)                                                                                                
Juneau, Alaska                                                                                                                  
POSITION STATEMENT:  Spoke as the drafter during discussion of                                                                
HB 327.                                                                                                                         
                                                                                                                                
REPRESENTATIVE BOB BUCH                                                                                                         
Alaska State Legislature                                                                                                        
Juneau, Alaska                                                                                                                  
POSITION STATEMENT:  Sponsor of HB 115.                                                                                       
                                                                                                                                
PHIL KEISLING                                                                                                                   
Portland, Oregon                                                                                                                
POSITION STATEMENT:  Provided comments during discussion of                                                                   
HB 115.                                                                                                                         
                                                                                                                                
GAIL FENUMIAI, Director                                                                                                         
Central Office                                                                                                                  
Division Of Elections                                                                                                           
Office of the Lieutenant Governor                                                                                               
Juneau, Alaska                                                                                                                  
POSITION STATEMENT:  Responded to  questions during discussion of                                                             
HB 115.                                                                                                                         
                                                                                                                                
ACTION NARRATIVE                                                                                                              
                                                                                                                                
1:07:51 PM                                                                                                                    
                                                                                                                                
CHAIR JAY  RAMRAS called the  House Judiciary  Standing Committee                                                             
meeting  to   order  at  1:07   p.m.     Representatives  Ramras,                                                               
Dahlstrom,  Herron, Gatto,  Lynn, and  Gruenberg were  present at                                                               
the call to order.   Representative Holmes arrived as the meeting                                                               
was in progress.                                                                                                                
                                                                                                                                
        HB 327 - CONTROLLED SUBSTANCES/DEXTROMETHORPHAN                                                                     
                                                                                                                                
1:09:08 PM                                                                                                                    
                                                                                                                                
CHAIR RAMRAS announced that the  first order of business would be                                                               
HOUSE  BILL NO.  327,  "An  Act relating  to  the scheduling  and                                                               
rescheduling of  certain substances as controlled  substances and                                                               
to the sale of products containing dextromethorphan."                                                                           
                                                                                                                                
1:09:29 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE KYLE JOHANSEN,  Alaska State Legislature, sponsor,                                                               
indicated that HB  327 - the three main provisions  of which were                                                               
requested  by three  different constituents  - would  add "Salvia                                                               
divinorum"   [and  its   main  active   compound  "Salvinorin   A                                                               
(Divinorin A)" - abused for  their hallucinogenic properties - to                                                               
the  list of  schedule IIA  drugs; would  change buprenorphine  -                                                               
used as a substitute for  methadone in opiate addiction therapies                                                               
but  also  subject to  abuse  -  from a  schedule  VA  drug to  a                                                               
schedule IIIA drug;  and would require that the  sale of products                                                               
containing dextromethorphan - abused  for its intoxicating effect                                                               
and found in many cough syrups  - be limited such that they could                                                               
not be sold to minors without  a prescription, and such that they                                                               
either be clearly  labeled to that effect or that  access to them                                                               
be restricted].                                                                                                                 
                                                                                                                                
CHAIR  RAMRAS  acknowledged  that  many  substances  -  including                                                               
cleaning  solvents -  are now  being abused  by those  seeking to                                                               
experience  an altered  state of  consciousness, and  offered his                                                               
understanding of what the provisions of HB 327 entail.                                                                          
                                                                                                                                
1:14:34 PM                                                                                                                    
                                                                                                                                
DAVID SCOTT,  Staff, Representative  Kyle Johansen,  Alaska State                                                               
Legislature, on  behalf of the sponsor,  Representative Johansen,                                                               
to clarify, reiterated some of the points made by the sponsor.                                                                  
                                                                                                                                
CHAIR  RAMRAS predicted  that  one of  the  issues the  committee                                                               
would be considering  is whether labeling a  product as dangerous                                                               
makes  it  more attractive  to  those  seeking to  experience  an                                                               
altered state of consciousness.                                                                                                 
                                                                                                                                
REPRESENTATIVE DAHLSTROM  - remarking  that she has  two military                                                               
bases in  her district,  that sometimes  the spouses  of military                                                               
personnel  are under  the age  of 18,  and that  sometimes minors                                                               
become emancipated  - said she  supports the intent of  the bill,                                                               
but  is concerned  about its  proposed requirement  that products                                                               
containing dextromethorphan  not be sold  to those under  the age                                                               
of 18 without a prescription.                                                                                                   
                                                                                                                                
MR. SCOTT explained that one  of those military bases - Elmendorf                                                               
Air Force  Base - already bans  the use of Salvia  Divinorum, and                                                               
already  requires that  products  containing dextromethorphan  be                                                               
kept behind the counter.                                                                                                        
                                                                                                                                
REPRESENTATIVE  HERRON questioned  why the  bill is  proposing to                                                               
add Salvia  divinorum [and "Salvinorin  A (Divinorin A)"]  to the                                                               
list of  schedule IIA drugs rather  than to the list  of schedule                                                               
IA drugs.                                                                                                                       
                                                                                                                                
MR.  SCOTT  offered  his  understanding  that  it's  because  its                                                               
chemical  makeup  and  effects  are similar  to  those  of  other                                                               
schedule IIA drugs.                                                                                                             
                                                                                                                                
CHAIR  RAMRAS  surmised  that  the  drafter  could  address  that                                                               
question further.                                                                                                               
                                                                                                                                
1:21:58 PM                                                                                                                    
                                                                                                                                
SUE  STANCLIFF, Special  Assistant, Office  of the  Commissioner,                                                               
Department  of  Public  Safety  (DPS),  indicated  that  the  DPS                                                               
supports  HB  327,  and  that although  the  DPS  recognizes  the                                                               
difficulty of  testing for [the  presence of Salvia  divinorum or                                                               
"Salvinorin A  (Divinorin A)" in  a person's system], the  DPS is                                                               
concerned about the effect of those  drugs on people who use them                                                               
while driving or  operating equipment.  Many  states have already                                                               
made  Salvia   divinorum  [and  "Salvinorin  A   (Divinorin  A)"]                                                               
illegal,  and several  more states  are considering  doing so  as                                                               
well.   According  to  a 2008  National Survey  on  Drug Use  and                                                               
Health Report published  by the federal Substance  Abuse & Mental                                                               
Health  Services   Administration  (SAMHSA),   approximately  1.8                                                               
million people over  the age of 11 have used  Salvia divinorum in                                                               
their lifetime, approximately 750,000  people have done so during                                                               
the prior  year, and  young adults were  three times  more likely                                                               
than youths  aged 12 to 17  to have used Salvia  divinorum during                                                               
the prior year.                                                                                                                 
                                                                                                                                
MS. STANCLIFF  recounted what  she'd heard  about the  effects of                                                               
Salvia  divinorum -  that it  leaves the  user feeling  unable to                                                               
control his/her own  movements - and that there  was one 17-year-                                                               
old who  committed suicide after  using Salvia  divinorum several                                                               
times over a period of months  and experiencing a sense that life                                                               
was  pointless.   Regardless  that  it's  difficult to  test  for                                                               
Salvia  divinorum use,  she  relayed,  Alaska's Scientific  Crime                                                               
Detection Laboratory  ("crime lab") is proactively  searching for                                                               
methods by which to do  so, particularly given that driving under                                                               
the influence  of Salvia  divinorum poses a  danger to  others on                                                               
the road.  In response  to questions regarding the enforcement of                                                               
the  bill's   provisions  pertaining  to   dextromethorphan,  she                                                               
indicated  that   the  DPS  is   primarily  concerned   with  and                                                               
supportive  of the  provisions of  HB 327  that would  add Salvia                                                               
divinorum  [and "Salvinorin  A  (Divinorin A)"]  to  the list  of                                                               
schedule IIA drugs.                                                                                                             
                                                                                                                                
CHAIR RAMRAS ventured that the committee supports HB 327.                                                                       
                                                                                                                                
1:32:31 PM                                                                                                                    
                                                                                                                                
LELA   RAYMOND    mentioned   that   her   son    began   abusing                                                               
dextromethorphan  in  March  29,  2008,  taking  a  product  that                                                               
contained  it  in order  to  "get  high,"  and  ended up  in  the                                                               
hospital  only 17  days later  due to  an overdose;  seven months                                                               
later, her son  had overdosed a total of eight  times, and during                                                               
two of those times, he  experienced some degree of organ failure.                                                               
Her  son's addiction  has affected  her entire  family, with  the                                                               
youngest children  now being fearful  that he will soon  die from                                                               
dextromethorphan   abuse.     Her  son   was  stealing   products                                                               
containing  dextromethorphan  from  grocery  stores,  where  such                                                               
products are  readily available.   She  noted that  another child                                                               
lost half of  her liver due to her dextromethorphan  abuse.  Some                                                               
years, dextromethorphan is  abused even more than  other types of                                                               
drugs, it shuts  down the person's whole body,  muscle by muscle,                                                               
organ by organ, and causes hallucinations.                                                                                      
                                                                                                                                
MS.   RAYMOND   pointed  out   that   when   young  girls   abuse                                                               
dextromethorphan,  it   renders  them  incapable   of  protecting                                                               
themselves  against  rape.    The  concept  of  abusing  products                                                               
containing  dextromethorphan to  experience an  altered state  of                                                               
consciousness  has spread  rapidly over  the Internet,  and there                                                               
are other  children in the  community experiencing  this problem.                                                               
Dextromethorphan abuse has become an  epidemic across the nation,                                                               
with one  out of every  eleven people  abusing it to  "get high."                                                               
In conclusion,  she relayed  that eventually, her  son had  to be                                                               
locked up  for his own  safety.  In  response to a  question, she                                                               
added that research  indicates that while 15 to  30 milligrams of                                                               
dextromethorphan  is  sufficient to  suppress  a  cough, and  100                                                               
milligrams is  sufficient to  cause hallucinations,  the children                                                               
in Ketchikan are consuming several  thousand milligrams at a time                                                               
and  daring each  other to  consume more  and more  - bottle  for                                                               
bottle - at each  [event].  Her son, she added,  had at one point                                                               
consumed six bottles, thereby almost ending his life.                                                                           
                                                                                                                                
MS.  RAYMOND,  in  response  to  another  question,  offered  her                                                               
understanding that  there are  about 120  common products  on the                                                               
market that  contain dextromethorphan,  and ventured some  of the                                                               
names of  some of those  products.  Unfortunately, most  of those                                                               
products also  contain many other  ingredients which,  when taken                                                               
in  excess,  cause  serious medical  complications  such  as  the                                                               
destruction of one's  liver.  People who abuse  such products are                                                               
seeking  the   effects  of  the  dextromethorphan,   and,  again,                                                               
products containing  it are readily  available and  accessible at                                                               
the grocery store.                                                                                                              
                                                                                                                                
1:41:42 PM                                                                                                                    
                                                                                                                                
REND  AL-MONDHIRY,  Esq.,  State  Legislative  Counsel,  Legal  &                                                               
Government  Affairs,  Consumer  Healthcare  Products  Association                                                               
(CHPA), after  mentioning that  the CHPA  is a  trade association                                                               
representing  the  nation's  leading manufacturers  of  over-the-                                                               
counter  medicines and  nutritional  supplements, explained  that                                                               
dextromethorphan  is a  safe and  effective  ingredient found  in                                                               
over  100  over-the-counter   cough-  and  cold-remedy  products.                                                               
Since  dextromethorphan's  approval by  the  U.S.  Food and  Drug                                                               
Administration (FDA)  in the  1950s, it has  been used  safely by                                                               
millions  of Americans  each year  to relieve  coughs due  to the                                                               
common cold and flu.   Unfortunately, there are reports that some                                                               
teenagers  and young  adults are  intentionally abusing  products                                                               
containing  dextromethorphan in  an  effort to  "get high";  this                                                               
involves taking extremely  large amounts - about  25-30 times the                                                               
recommended dose.                                                                                                               
                                                                                                                                
MS. AL-MONDHIRY  said that  the CHPA  supports the  "age-18 sales                                                               
restrictions," and applauds the purpose  of HB 327.  However, the                                                               
CHPA  opposes  language  that  would  limit  or,  in  this  case,                                                               
potentially cut off  consumer access to cough  and cold medicines                                                               
by requiring that such products  be placed behind the counter, or                                                               
that requires these  products to have special  labeling; the CHPA                                                               
believes that such requirements  are unnecessary, unworkable, and                                                               
not in  the public  interest.   The CHPA  and the  companies that                                                               
manufacture  products  containing dextromethorphan  believe  that                                                               
education  is the  most effective  way to  prevent cough-medicine                                                               
abuse by teenagers, and so for  several years the CHPA has teamed                                                               
up  with  the  nation's  leading  anti-drug-abuse  and  education                                                               
organizations   to  raise   awareness   among   parents  and   in                                                               
communities about the dangers of cough medicine abuse.                                                                          
                                                                                                                                
MS. AL-MONDHIRY  then listed some  of the  CHPA's accomplishments                                                               
in  that  regard, including  its  work  with Community  Anti-Drug                                                               
Coalitions  of  America  (CADCA),  Partnership  for  a  Drug-Free                                                               
America  (PDFA),  Drug   Abuse  Resistance  Education  (D.A.R.E.)                                                               
America,   Abbott  Laboratories,   Pharmaceutical  Research   and                                                               
Manufacturers of America (PhRMA), and  WebMD, LLC, and the launch                                                               
of its  online grassroots campaign,  "Five Moms:   Stopping Cough                                                               
Medicine Abuse".   More  information about  these efforts  can be                                                               
found on the Internet at "StopMedicineAbuse.org".                                                                               
                                                                                                                                
MS.  AL-MONDHIRY,  in  response  to a  question,  explained  that                                                               
because currently  there is no alternative  to dextromethorphan -                                                               
the most  effective cough suppressant  available - if  stores are                                                               
required to keep products  containing dextromethorphan behind the                                                               
counter  or otherwise  limit access  to them,  they will  instead                                                               
simply stop carrying those products.                                                                                            
                                                                                                                                
1:46:35 PM                                                                                                                    
                                                                                                                                
RENEE SCHOFIELD,  CEO, Tongass  Substance Screening,  Inc. (TSS),                                                               
relayed that her company focuses on  the health and safety of the                                                               
community, offering a  wide range of services  including drug and                                                               
alcohol  testing.   She explained  that five  years ago,  the TSS                                                               
received  one call  about dextromethorphan  and  the problems  it                                                               
creates;  that three  years ago,  the  TSS received  five or  six                                                               
calls; and  that currently,  the TSS  receives calls  every week.                                                               
This  indicates a  rampant escalation  in the  abuse of  products                                                               
containing dextromethorphan,  which is  a good product  when used                                                               
appropriately.    Unfortunately,  today's  youth  are  finding  a                                                               
variety of  ways to misuse the  drugs they have ready  access to:                                                               
products  containing  dextromethorphan are  easy  to  get at  the                                                               
grocery  store  and are  available  in  almost  all homes.    She                                                               
suggested  that  families  with  children,  regardless  of  their                                                               
children's  age,   should  keep  such  products   locked  up  and                                                               
inaccessible to their children.                                                                                                 
                                                                                                                                
MS. SCHOFIELD relayed that the  TSS has also been receiving calls                                                               
from concerned parents regarding  their children's possession and                                                               
use of Salvia divinorum.   With regard to buprenorphine, she said                                                               
that it,  too, is a  good drug when used  appropriately; however,                                                               
it appears  that it  is getting  overprescribed, and  then people                                                               
are selling  their prescriptions [to  those seeking to  abuse the                                                               
drug].    In conclusion,  she  said  that  she supports  HB  327;                                                               
remarked that the  intent of the bill is  good; acknowledged that                                                               
there may still be a few  problems with regard to testing for the                                                               
substances the  bill is  focused on; and  predicted that  as more                                                               
states address these  substances someone will find a  way to test                                                               
for  their  presence in  a  person's  system, thereby  protecting                                                               
children  so that  they  may  indeed become  the  leaders of  the                                                               
future.                                                                                                                         
                                                                                                                                
1:51:19 PM                                                                                                                    
                                                                                                                                
BARRY  CHRISTENSEN,   Co-Chair,  Legislative   Committee,  Alaska                                                               
Pharmacists Association  (APA), relayed that the  APA opposes the                                                               
provisions of  HB 327 pertaining  to dextromethorphan,  with most                                                               
members   being   opposed   because   they've   been   dispensing                                                               
dextromethorphan  for  a  number  of years  without  issue.    He                                                               
acknowledged, however,  that testimony  heard thus  far indicates                                                               
that there are  now some problems with abuse, and  so the members                                                               
of the  APA are willing  and able to  help with enforcement.   In                                                               
response  to  questions, he  indicated  that  having to  check  a                                                               
customer's   government-issued  photo   identification  (ID)   to                                                               
determine that  he/she is at least  18 years of age  would not be                                                               
much of  a burden, and neither  would refusing to sell  a product                                                               
containing  dextromethorphan  to  a  minor unless  he/she  had  a                                                               
prescription.    The language  of  the  bill that  is  troubling,                                                               
however,   is   the    requirement   that   products   containing                                                               
dextromethorphan be  placed behind the counter;  the concern with                                                               
that  requirement  is that  there  are  a  lot of  products  that                                                               
contain  dextromethorphan and  so  to move  them  all behind  the                                                               
counter would raise shelving issues.                                                                                            
                                                                                                                                
CHAIR  RAMRAS  pointed  out,  though, that  in  lieu  of  placing                                                               
products  containing dextromethorphan  behind the  counter, those                                                               
selling such  products could simply  label them as for  sale only                                                               
to persons  18 years of age  or by prescription.   Observing that                                                               
the Department of Law has  submitted an indeterminate fiscal note                                                               
for HB  327, he surmised that  the bill would be  referred to the                                                               
House Finance Committee.                                                                                                        
                                                                                                                                
MR.  SCOTT, in  response  to a  question,  acknowledged that  the                                                               
committee could choose  to delete the requirement  that access to                                                               
products containing dextromethorphan be limited.                                                                                
                                                                                                                                
REPRESENTATIVE HERRON indicated that he  would be opposed to such                                                               
a change.                                                                                                                       
                                                                                                                                
MR.  CHRISTENSEN,   in  response   to  comments   and  questions,                                                               
indicated acceptance of the bill's current language.                                                                            
                                                                                                                                
MR. SCOTT, in response to  questions, acknowledged that under the                                                               
bill, those  who sell products containing  dextromethorphan would                                                               
be required to  check a customer's government-issued  photo ID to                                                               
verify that the  customer was at least 18 years  of age, and that                                                               
retailers,  sellers,  and  vendors  of  such  products  would  be                                                               
responsible for training their employees to that effect.                                                                        
                                                                                                                                
REPRESENTATIVE  GATTO opined  that requiring  employees to  check                                                               
customers' IDs would be too burdensome.                                                                                         
                                                                                                                                
CHAIR   RAMRAS   disagreed,   and  pointed   out   that   similar                                                               
requirements  are already  in place  with regard  to the  sale of                                                               
certain  other products  such as  [tobacco,]  alcohol, and  those                                                               
containing ephedrine or pseudoephedrine.                                                                                        
                                                                                                                                
2:04:42 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE HOLMES said  that according to her  reading of the                                                               
provisions pertaining  to dextromethorphan, a violation  would be                                                               
a class  B misdemeanor, and  would apply to whoever  violated the                                                               
provisions, whether that  be the seller, retailer,  or vender, or                                                               
his/her employee.   She questioned  how retailers  would restrict                                                               
the public's access to products containing dextromethorphan.                                                                    
                                                                                                                                
[Chair Ramras turned the gavel over to Representative Herron.]                                                                  
                                                                                                                                
MR.  SCOTT  ventured  that  it  would be  up  to  the  individual                                                               
retailer to decide  whether to label the products  or to restrict                                                               
access to  them, and, if  the latter,  to decide how  to restrict                                                               
access.   Very small  stores, those without  any room  behind the                                                               
counter, would  probably choose to label  the products containing                                                               
dextromethorphan, he surmised.                                                                                                  
                                                                                                                                
[Representative Herron returned the gavel to Chair Ramras.]                                                                     
                                                                                                                                
MR. SCOTT,  in response to  another question, ventured  that some                                                               
retailers    might   choose    to    put   products    containing                                                               
dextromethorphan in locked cases rather  than behind the counter.                                                               
The language  in the  bill that  says, "limit  the access  of the                                                               
public to  the product by  its placement  behind a counter  or by                                                               
similar  means"  provides  retailers  with  flexibility  in  that                                                               
regard.                                                                                                                         
                                                                                                                                
REPRESENTATIVE  HERRON   surmised  that  limiting   access  could                                                               
involve just  placing the  products where a  customer has  to ask                                                               
for them instead of where he/she can reach them himself/herself.                                                                
                                                                                                                                
REPRESENTATIVE  GRUENBERG pointed  out  that a  violation of  the                                                               
provisions pertaining  to dextromethorphan could be  applied to a                                                               
corporation, since the term, "a person"  - as used in proposed AS                                                               
17.30.095  - is  defined in  AS 11.81.900(b)(45)  as, "a  natural                                                               
person  and, when  appropriate, an  organization, government,  or                                                               
governmental  instrumentality;" and  the term,  "organization" is                                                               
defined in AS  11.81.900(b)(43) as, "a legal  entity, including a                                                               
corporation,  company,  association,   firm,  partnership,  joint                                                               
stock  company,  foundation,  institution,  government,  society,                                                               
union, club, church, or any  other group of persons organized for                                                               
any purpose;".                                                                                                                  
                                                                                                                                
CHAIR RAMRAS, in response to  questions and comments, opined that                                                               
it is  necessary to protect  young people from their  attempts at                                                               
experimentation with  mind-altering substances, and  posited that                                                               
HB 327 would help.                                                                                                              
                                                                                                                                
REPRESENTATIVE  GRUENBERG pointed  out  that a  violation of  the                                                               
provisions pertaining to dextromethorphan  requires a mens rea of                                                               
recklessly,  and   that  a  person   could  violate   either  the                                                               
requirement  that a  product containing  dextromethorphan not  be                                                               
sold to a  person under the age of 18  without a prescription, or                                                               
the  requirement that  such products  either be  labeled to  that                                                               
effect or that access to them be restricted.                                                                                    
                                                                                                                                
MR.  CHRISTENSEN   referred  to  the  requirement   that  vendors                                                               
sellers, and retailers determine  that their employees and agents                                                               
have  been  notified  of  the   requirements  of  the  provisions                                                               
pertaining to  dextromethorphan, and questioned what  the phrase,                                                               
"making another appropriate determination" would entail.                                                                        
                                                                                                                                
2:21:13 PM                                                                                                                    
                                                                                                                                
GERALD   LUCKHAUPT,   Attorney,    Legislative   Legal   Counsel,                                                               
Legislative  Legal  and  Research Services,  Legislative  Affairs                                                               
Agency  (LAA),  speaking  as the  drafter,  explained  that  that                                                               
phrase  is  meant  to  provide another  mechanism  -  other  than                                                               
obtaining  an employee  or agent's  written  acknowledgment -  by                                                               
which  vendors sellers,  and retailers  could  ensure that  their                                                               
employees and  agents have been  notified of the  requirements of                                                               
the provisions  pertaining to dextromethorphan.   That  phrase is                                                               
part  of the  existing law  pertaining  to the  sale of  products                                                               
containing  ephedrine or  pseudoephedrine, and  there is  similar                                                               
language in the laws pertaining to the sale of tobacco products.                                                                
                                                                                                                                
MR. LUCKHAUPT,  in response to  the question  of why the  bill is                                                               
proposing   to   add   Salvia  divinorum   [and   "Salvinorin   A                                                               
(Divinorin A)"] to the list of  schedule IIA drugs rather than to                                                               
the list of  schedule IA drugs, explained  that [Salvia divinorum                                                               
and "Salvinorin  A (Divinorin  A)"] are  not currently  listed as                                                               
scheduled   substances   by   the  federal   government,   though                                                               
legislation to list them as  schedule I substances was introduced                                                               
[in 2002] but  not adopted; that although  the federal government                                                               
lists marijuana  and all [hallucinogenic] substances  as schedule                                                               
I  substances, in  Alaska,  all  [hallucinogenic] substances  are                                                               
listed as  schedule IIA substances  and marijuana is listed  as a                                                               
schedule  VIA substance,  and  so  the language  of  the bill  is                                                               
consistent with  that practice; and  that in Alaska,  things like                                                               
[opium and] heroin are listed  as schedule IA substances, whereas                                                               
the federal government,  for the most part, lists  such things as                                                               
schedule II substances.                                                                                                         
                                                                                                                                
MR.  LUCKHAUPT, with  regard to  the bill's  proposed requirement                                                               
that products  containing dextromethorphan  not be sold  to those                                                               
under  the  age of  18  without  a  prescription, noted  that  in                                                               
similar  statutes  regarding  the  sale  of  products  containing                                                               
[ephedrine or  pseudoephedrine] the age threshold  was changed to                                                               
16  years  of  age  in  order to  address  underage  spouses  and                                                               
emancipated minors.                                                                                                             
                                                                                                                                
2:25:26 PM                                                                                                                    
                                                                                                                                
CHAIR  RAMRAS made  a motion  to adopt  Amendment 1,  labeled 26-                                                               
LS1261\R.1, Luckhaupt, 3/10/10, which read:                                                                                     
                                                                                                                                
     Page 3, line 7:                                                                                                            
     Insert a new bill section to read:                                                                                         
        "* Sec. 3. AS 11.71.170(b) is amended to read:                                                                      
          (b)  Schedule IVA includes, unless specifically                                                                       
     excepted  or unless  listed  in  another schedule,  any                                                                    
     material,  compound,  mixture,   or  preparation  which                                                                    
     contains  any  quantity  of the  following  substances,                                                                    
     including  their salts,  isomers and  salts of  isomers                                                                    
     whenever  the existence  of these  salts, isomers,  and                                                                    
     salts  of  isomers  is  possible  within  the  specific                                                                    
     chemical designation:                                                                                                      
               (1)  barbital;                                                                                                   
               (2)  chloral betaine;                                                                                            
               (3)  chloral hydrate;                                                                                            
               (4)  chlordiazepoxide;                                                                                           
               (5)  clonazepam;                                                                                                 
               (6)  clorazepate;                                                                                                
               (7)  diazepam;                                                                                                   
               (8)  ethclorvynol;                                                                                               
               (9)  ethinamate;                                                                                                 
               (10)  flurazepam;                                                                                                
               (11)  lorazepam [LORAZEPAN];                                                                                 
               (12)  mebutamate;                                                                                                
               (13)  meprobamate;                                                                                               
               (14)  methohexital;                                                                                              
               (15)  methylphenobarbital, also known as                                                                         
     mephobarbital;                                                                                                             
               (16)  oxazepam;                                                                                                  
               (17)  paraldehyde;                                                                                               
               (18)  petrichloral;                                                                                              
               (19)  phenobarbital;                                                                                             
               (20)  prazepam;                                                                                                  
               (21)  alprazolam;                                                                                                
               (22)  halazepam;                                                                                                 
               (23)  temazepam;                                                                                                 
               (24)  triazolam;                                                                                                 
               (25)  midazolam;                                                                                                 
               (26)  quazepam;                                                                                                  
               (27)  flunitrazepam;                                                                                             
               (28)  [REPEALED                                                                                                  
               (29)]  ketamine hydrochloride."                                                                                  
                                                                                                                                
     Renumber the following bill sections accordingly.                                                                          
                                                                                                                                
     Page 4, following line 1:                                                                                                  
     Insert a new bill section to read:                                                                                         
        "*  Sec.  6. The  uncodified  law  of the  State  of                                                                
     Alaska is amended by adding a new section to read:                                                                         
          APPLICABILITY. AS 11.71.170(b)(11), as amended by                                                                     
     sec. 3 of  this Act, corrects a  typographical error in                                                                    
     the spelling of "lorazepam"  that has existed since its                                                                    
     adoption in Chapter  45, SLA 1982. AS 11.71.170(b)(11),                                                                    
     as amended  by sec.  3 of this  Act, applies  to crimes                                                                    
      committed before, on, or after the effective date of                                                                      
     this Act."                                                                                                                 
                                                                                                                                
CHAIR  RAMRAS  explained  that Amendment  1  simply  addresses  a                                                               
spelling error in current statute.                                                                                              
                                                                                                                                
CHAIR RAMRAS,  after ascertaining that there  were no objections,                                                               
announced that Amendment 1 was adopted.                                                                                         
                                                                                                                                
2:25:49 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE HERRON made a motion  to adopt Amendment 2, to add                                                               
Salvia divinorum [and  "Salvinorin A (Divinorin A)"]  to the list                                                               
of schedule IA substances instead of  to the list of schedule IIA                                                               
substances.                                                                                                                     
                                                                                                                                
REPRESENTATIVE DAHLSTROM objected for  the purpose of discussion,                                                               
and raised the issues of detection and enforcement.                                                                             
                                                                                                                                
MR.  LUCKHAUPT,  in  response, indicated  that  there  are  tests                                                               
available to  determine whether a substance  is Salvia divinorum,                                                               
but  not  whether a  person  is  under  the influence  of  Salvia                                                               
divinorum  [or   "Salvinorin  A  (Divinorin  A)"];   that  Salvia                                                               
divinorum  is  part  of  the  mint family;  and  that  if  Salvia                                                               
divinorum [and "Salvinorin A (Divinorin  A)"] were instead listed                                                               
as  schedule IA  substances, slightly  increased penalties  would                                                               
then  be  available.    In   response  to  another  question,  he                                                               
clarified  that  Alaska  classifies  schedule  IA  substances  as                                                               
having  the highest  degree of  danger  or probable  danger to  a                                                               
person or  the public, whereas the  federal government classifies                                                               
schedule I  substances as having  no medicinal use.   In response                                                               
to further questions,  he indicated that it might  be possible to                                                               
buy Salvia divinorum in certain  shops, since currently it is not                                                               
regulated  by the  federal  government.   He  reiterated that  in                                                               
Alaska  all [hallucinogenic]  drugs  are listed  as schedule  IIA                                                               
substances.                                                                                                                     
                                                                                                                                
REPRESENTATIVE  GATTO  indicated  disfavor with  the  concept  of                                                               
listing Salvia divinorum [and "Salvinorin  A (Divinorin A)"] as a                                                               
more dangerous  substance than  the other  [hallucinogenic] drugs                                                               
currently  listed  as schedule  IIA  substances,  as Amendment  2                                                               
proposes to do.                                                                                                                 
                                                                                                                                
REPRESENTATIVE   HERRON  argued   that   Salvia  divinorum   [and                                                               
"Salvinorin A  (Divinorin A)"]  should be  listed as  schedule IA                                                               
substances in Alaska simply because  the federal government lists                                                               
drugs that have no medicinal use as schedule I substances.                                                                      
                                                                                                                                
2:31:04 PM                                                                                                                    
                                                                                                                                
A roll  call vote was  taken.  Representatives Herron,  Lynn, and                                                               
Ramras voted  in favor  of Amendment  2.   Representatives Gatto,                                                               
Gruenberg, Holmes,  and Dahlstrom  voted against it.   Therefore,                                                               
Amendment 2 failed by a vote of 3-4.                                                                                            
                                                                                                                                
2:31:34 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  DAHLSTROM  made  a  motion  to  adopt  Conceptual                                                               
Amendment 3, [to allow underage  spouses, emancipated minors, and                                                               
minors   who  are   parents  to   purchase  products   containing                                                               
dextromethorphan  without  a  prescription].     There  being  no                                                               
objection, Conceptual Amendment 3 was adopted.                                                                                  
                                                                                                                                
2:32:57 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE DAHLSTROM moved to report  HB 327, as amended, out                                                               
of   committee   with    individual   recommendations   and   the                                                               
accompanying  fiscal  notes.   There  being  no  objection,  CSHB
327(JUD)  was   reported  from   the  House   Judiciary  Standing                                                               
Committee.                                                                                                                      
                                                                                                                                
               HB 115 - PERMANENT ABSENTEE VOTING                                                                           
                                                                                                                                
2:34:02 PM                                                                                                                    
                                                                                                                                
CHAIR RAMRAS announced  that the next order of  business would be                                                               
HOUSE BILL  NO. 115,  "An Act  establishing a  permanent absentee                                                               
voting  option  for  qualified   voters;  and  providing  for  an                                                               
effective date."  [Before the committee was CSHB 115(STA).]                                                                     
                                                                                                                                
2:34:35 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  BOB  BUCH,  Alaska  State  Legislature,  sponsor,                                                               
indicated  that HB  115  would simply  make  voting via  absentee                                                               
ballot more  convenient [by providing  voters with the  option of                                                               
registering as  a permanent absentee voter  for state elections],                                                               
that it would  make no other changes to  Alaska's voting process,                                                               
and that providing for permanent  absentee voting status] has met                                                               
with great  success.   Currently, 8 other  states have  a similar                                                               
option available,  and 21 other  states are  considering adopting                                                               
similar legislation.   In response to questions,  he relayed that                                                               
the  Division of  Elections supports  HB 115,  and that  the bill                                                               
would help those in the military and those who are [housebound].                                                                
                                                                                                                                
CHAIR  RAMRAS expressed  concern that  HB  115 would  be used  by                                                               
military personnel  to commit more permanent  fund dividend (PFD)                                                               
fraud.                                                                                                                          
                                                                                                                                
REPRESENTATIVE BUCH  offered his belief  that it would  not, that                                                               
existing  safeguards within  the  Division of  Elections and  the                                                               
United   States   Postal   Service  (USPS)   regarding   absentee                                                               
ballots/voting  are sufficient  to prevent  any such  increase in                                                               
fraudulent  PFD filings.   Under  the bill,  a person  must first                                                               
apply  with  the Division  of  Elections  for permanent  absentee                                                               
voter  status, and  then  [if the  application  is approved]  the                                                               
Division of  Elections would send  the person an  absentee ballot                                                               
[each appropriate election cycle].                                                                                              
                                                                                                                                
CHAIR  RAMRAS  reiterated  his  concern,  but  acknowledged  that                                                               
military personnel are not the only ones who commit PFD fraud.                                                                  
                                                                                                                                
REPRESENTATIVE GRUENBERG  noted that  members' packets  include a                                                               
letter from  the Division of  Elections dated February  24, 2010,                                                               
that addresses the  issue of fraud.  He also  noted that when the                                                               
bill was heard  in its last committee of referral,  a concern was                                                               
raised regarding  whether the  bill has  potential constitutional                                                               
or  legal  problems.   That  concern  has  been addressed  via  a                                                               
memorandum  from Legislative  Legal and  Research Services  dated                                                               
February  23,  2010; this  memorandum  indicates  that under  the                                                               
federal Voting  Rights Act of  1965, the bill's  proposed changes                                                               
to Alaska's voting  practices/procedures require preclearance [by                                                               
the Department of Justice's (DOJ's) Civil Rights Division].                                                                     
                                                                                                                                
2:43:07 PM                                                                                                                    
                                                                                                                                
PHIL KEISLING  relayed that  he served  as Oregon's  secretary of                                                               
state  from  1991   through  1999;  and  that   in  1995,  Oregon                                                               
implemented a  statutory permanent  absentee voting  provision to                                                               
address  the fact  that as  the result  of a  "get out  the vote"                                                               
strategy, election officials were  getting deluged prior to every                                                               
election with  requests for absentee  ballots.  People  liked the                                                               
convenience of voting by mail,  but didn't like having to request                                                               
an absentee ballot  for every election.   Furthermore, there were                                                               
costs  associated with  processing new  absentee ballot  requests                                                               
every  election.   The permanent  absentee  voting provision  has                                                               
proved  to be  very  popular, has  reduced  costs, has  increased                                                               
voter turnout, has  reduced the chance of mistakes,  and has made                                                               
it easier to detect election fraud.                                                                                             
                                                                                                                                
2:50:34 PM                                                                                                                    
                                                                                                                                
GAIL FENUMIAI,  Director, Central Office, Division  Of Elections,                                                               
Office  of the  Lieutenant  Governor, in  response to  questions,                                                               
said that the  Division of Elections doesn't believe  that HB 115                                                               
would contribute to any increased  incidents of voter fraud; that                                                               
during  her 12-plus  years with  the Division  of Elections,  she                                                               
hasn't ever  encountered any voter fraud  resulting from Alaska's                                                               
absentee  ballot process;  that she  is  unable to  speak to  the                                                               
issue of  PFD fraud;  that the Division  of Elections  has spoken                                                               
with  a  former Oregon  election  official  who had  nothing  but                                                               
positive  things  to  say about  its  permanent  absentee  voting                                                               
provision  by   mail  system,  feeling   that  it   enhanced  the                                                               
opportunity for  voters to participate  in the  election process;                                                               
and that at  this time she is not able  to provide any statistics                                                               
regarding the eventual increased voter turnout in Oregon.                                                                       
                                                                                                                                
REPRESENTATIVE  BUCH  indicated  that  members'  packets  contain                                                               
information  illustrating that  at  times,  Oregon experienced  a                                                               
voter turnout of  up to 80 percent due to  that state's permanent                                                               
absentee voting provision.                                                                                                      
                                                                                                                                
REPRESENTATIVE  GATTO,  referring  to statistics  provided  in  a                                                               
letter from  the president of  the American Postal  Workers Union                                                               
dated February  10, 2010, indicated  that he is  questioning what                                                               
impact  HB 115  would have  on the  integrity of  Alaska's voting                                                               
process.                                                                                                                        
                                                                                                                                
MS. FENUMIAI, in response to  questions and comments, offered her                                                               
understanding of  how the voting  system works in  Oregon; stated                                                               
that as the  director of the Division of  Elections, she believes                                                               
it's important  for everyone  who is eligible  to vote,  to vote;                                                               
and  said she  would  prefer  not to  pass  personal judgment  on                                                               
voters who may not be living in the state.                                                                                      
                                                                                                                                
REPRESENTATIVE  BUCH, in  response to  questions, indicated  that                                                               
voters  could benefit  from the  adoption  of HB  115 because  it                                                               
would be safer  for them to receive their ballots  by mail rather                                                               
than risk having  to get themselves to  their election district's                                                               
voting  venue;  and  that  he  had  not  asked  anyone  from  the                                                               
Permanent Fund Dividend Division to  come speak on HB 115 because                                                               
his  intention  with  the  bill   is  to  address  the  issue  of                                                               
elections, not PFDs  or PFD fraud, which he  surmised, is already                                                               
being  adequately  addressed  by   the  Permanent  Fund  Dividend                                                               
Division.                                                                                                                       
                                                                                                                                
The committee took an at-ease from 3:01 p.m. to 3:02 p.m.                                                                       
                                                                                                                                
CHAIR RAMRAS indicated  a belief that HB 115  should also address                                                               
the issue of  PFD fraud, and relayed that HB  115 would therefore                                                               
be held over.                                                                                                                   
                                                                                                                                
           HB 355 - CRIMINAL FINES FOR ORGANIZATIONS                                                                        
                                                                                                                                
3:06:33 PM                                                                                                                    
                                                                                                                                
CHAIR RAMRAS announced that the  final order of business would be                                                               
HOUSE  BILL NO.  355,  "An  Act relating  to  criminal fines  for                                                               
organizations."                                                                                                                 
                                                                                                                                
REPRESENTATIVE  GRUENBERG,  speaking  as the  sponsor,  explained                                                               
that  HB  355  and  a proposed  amendment  included  in  members'                                                               
packets would  bring criminal penalties  for organizations  up to                                                               
date, and  would cure  a loophole in  current law;  that proposed                                                               
amendment,  labeled  26-LS1385\E.1,   Luckhaupt,  3/9/10,  [which                                                               
later became known as Amendment 1] read:                                                                                        
                                                                                                                                
     Page 1, line 7:                                                                                                            
          Delete "$1,000,000"                                                                                                   
          Insert "$2,000,000 [$1,000,000]"                                                                                  
                                                                                                                                
     Page 1, line 9:                                                                                                            
          Delete "$200,000"                                                                                                     
          Insert "$400,000 [$200,000]"                                                                                      
                                                                                                                                
     Page 1, line 11:                                                                                                           
          Delete "$25,000"                                                                                                      
          Insert "$50,000 [$25,000]"                                                                                        
                                                                                                                                
     Page 1, line 13:                                                                                                           
          Delete "$10,000"                                                                                                      
          Insert "$20,000 [$10,000]"                                                                                        
                                                                                                                                
REPRESENTATIVE    GRUENBERG,   in    conclusion,   offered    his                                                               
understanding that HB 355 enjoys support.                                                                                       
                                                                                                                                
[HB 355 was held over.]                                                                                                         
                                                                                                                                
3:07:32 PM                                                                                                                    
                                                                                                                                
ADJOURNMENT                                                                                                                   
                                                                                                                                
There being no further business before the committee, the House                                                                 
Judiciary Standing Committee meeting was adjourned at 3:07 p.m.                                                                 

Document Name Date/Time Subjects
01 HB327 Sponsor Statement.pdf HJUD 3/10/2010 1:00:00 PM
HB 327
02 HB327 Bill v. R.pdf HJUD 3/10/2010 1:00:00 PM
HB 327
03 HB327-DPS-LAB-03-08-10.pdf HJUD 3/10/2010 1:00:00 PM
HB 327
04 HB327 DXM Leg Research Report.pdf HJUD 3/10/2010 1:00:00 PM
HB 327
05 HB327 DXM Backup.pdf HJUD 3/10/2010 1:00:00 PM
HB 327
06 HB327 DXM Backup ER visits.pdf HJUD 3/10/2010 1:00:00 PM
HB 327
07 HB327 Salvia Backup.pdf HJUD 3/10/2010 1:00:00 PM
HB 327
08 HB327 Salvia Backup 2.pdf HJUD 3/10/2010 1:00:00 PM
HB 327
09 HB327 Buprenoorphine Backup.pdf HJUD 3/10/2010 1:00:00 PM
HB 327
10 HB327 USAF Ban Backup.pdf HJUD 3/10/2010 1:00:00 PM
HB 327
11 HB327 CHPA Testimony.pdf HJUD 3/10/2010 1:00:00 PM
HB 327
01 HB115 Sponsor Statement.pdf HJUD 3/10/2010 1:00:00 PM
HB 115
02 HB115 STA CS v. E.pdf HJUD 3/10/2010 1:00:00 PM
HB 115
03 HB115 Sectional Analysis.pdf HJUD 3/10/2010 1:00:00 PM
HB 115
04 HB115-OOG-DOE-2-12-10.pdf HJUD 3/10/2010 1:00:00 PM
HB 115
05 HB115 Bill v. A.pdf HJUD 3/10/2010 1:00:00 PM
HB 115
06 HB115 APWU letter of Support.pdf HJUD 3/10/2010 1:00:00 PM
HB 115
07 HB115 Legal Opinion.pdf HJUD 3/10/2010 1:00:00 PM
HB 115
08 HB115 DoE letter.pdf HJUD 3/10/2010 1:00:00 PM
HB 115
11 HB327-LAW-CRIM-03-08-10.pdf HJUD 3/10/2010 1:00:00 PM
HB 327
01 HB355 Sponsor Statement.pdf HJUD 3/10/2010 1:00:00 PM
HB 355
02 HB355 Bill v. E.pdf HJUD 3/10/2010 1:00:00 PM
HB 355
03 HB355-LAW-CRIM-03-08-10.pdf HJUD 3/10/2010 1:00:00 PM
HB 355
04 HB355 Law Review Article.pdf HJUD 3/10/2010 1:00:00 PM
HB 355